monospecific antibodies | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

3,842 results for “monospecific antibodies”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

HPA Antibodies and the Distribution of Antigen and Antibodies

6,170 participants · First posted Jan 23, 2018

Not yet recruiting

Phase 1, Open Label Clinical Trial to Treat Stage IV Cancer Patients With Multiple Patient-specific Mutated Cell Surface Proteins With Chimeric Antibodies

16 participants · First posted Aug 25, 2026

Enrolling By Invitation

Clinical Trial to Treat Stage IV Cancer Patients

12 participants · First posted Nov 5, 2024

Definition for Biliary Atresia Associated Cholangitis After Surgery

500 participants · First posted Jul 19, 2022

Two Anti-CD20 Regimens for Fibrillary Glomerulonephritis

21 participants · First posted Nov 8, 2024

Clinical Significance of Antiphospholipid Antibodies in Healthy Subjects

1,282 participants · First posted Jun 17, 2016

Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

33 participants · First posted May 29, 2018

Nivolumab in Relapsed Pediatric Solid Tumors

30 participants · First posted Sep 15, 2016

Active, not recruiting

anti_endometrial Antibodies in Endometriosis

30 participants · First posted May 9, 2023

Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy

19 participants · First posted Aug 24, 2016

Page 1 of 109